<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. <MULTIPLIER> 1,000 <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> DEC-31-2000 <PERIOD-START> JAN-01-2000 <PERIOD-END> SEP-30-2000 <CASH> 877 <SECURITIES> 0 <RECEIVABLES> 1,546 <F1> <ALLOWANCES> 0 <INVENTORY> 504 <CURRENT-ASSETS> 3,466 <PP&E> 1,939 <F1> <DEPRECIATION> 0 <TOTAL-ASSETS> 8,675 <CURRENT-LIABILITIES> 8,636 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 12,196 <COMMON> 140 <OTHER-SE> (100) <TOTAL-LIABILITY-AND-EQUITY> 8,675 <SALES> 7,003 <TOTAL-REVENUES> 14,620 <CGS> 5,067 <TOTAL-COSTS> 10,241 <OTHER-EXPENSES> 3,394 <F2> <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 454 <INCOME-PRETAX> (9,996) <INCOME-TAX> 15 <INCOME-CONTINUING> (10,010) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (10,010) <EPS-BASIC> (1.10) <F3> <EPS-DILUTED> (1.10) <FN> <F1> Item shown net of allowance, consistent with the balance sheet presentation. <F2> Item consists of research and development. <F3> Item consists of basic earnings per share. </FN>